vs
Side-by-side financial comparison of ENNIS, INC. (EBF) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
ENNIS, INC. is the larger business by last-quarter revenue ($100.2M vs $75.5M, roughly 1.3× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 0.4%). ENNIS, INC. produced more free cash flow last quarter ($15.7M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 1.4%).
ENNIS, INC. (ticker EBF) is a leading North American provider of printed business products and related services. Its offerings include custom business forms, pressure-sensitive labels, marketing collateral, promotional items, and branded packaging, serving clients across retail, healthcare, financial services, and small business segments.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
EBF vs PBYI — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $100.2M | $75.5M |
| Net Profit | $10.8M | — |
| Gross Margin | 31.9% | 69.3% |
| Operating Margin | 15.0% | 22.7% |
| Net Margin | 10.8% | — |
| Revenue YoY | 0.4% | 27.7% |
| Net Profit YoY | 6.1% | — |
| EPS (diluted) | $0.42 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $100.2M | $75.5M | ||
| Q3 25 | $98.7M | $54.5M | ||
| Q2 25 | $97.2M | $52.4M | ||
| Q1 25 | $92.7M | $46.0M | ||
| Q4 24 | $99.8M | $59.1M | ||
| Q3 24 | $99.0M | $80.5M | ||
| Q2 24 | $103.1M | $47.1M | ||
| Q1 24 | $97.4M | $43.8M |
| Q4 25 | $10.8M | — | ||
| Q3 25 | $13.2M | $8.8M | ||
| Q2 25 | $9.8M | $5.9M | ||
| Q1 25 | $9.0M | $3.0M | ||
| Q4 24 | $10.2M | — | ||
| Q3 24 | $10.3M | $20.3M | ||
| Q2 24 | $10.7M | $-4.5M | ||
| Q1 24 | $10.1M | $-4.8M |
| Q4 25 | 31.9% | 69.3% | ||
| Q3 25 | 30.5% | 77.7% | ||
| Q2 25 | 31.1% | 76.5% | ||
| Q1 25 | 29.5% | 77.1% | ||
| Q4 24 | 29.3% | 76.4% | ||
| Q3 24 | 30.1% | 63.9% | ||
| Q2 24 | 30.0% | 77.4% | ||
| Q1 24 | 28.4% | 75.5% |
| Q4 25 | 15.0% | 22.7% | ||
| Q3 25 | 12.5% | 17.6% | ||
| Q2 25 | 13.7% | 12.7% | ||
| Q1 25 | 13.0% | 8.7% | ||
| Q4 24 | 13.1% | 22.6% | ||
| Q3 24 | 13.3% | 27.4% | ||
| Q2 24 | 13.3% | -4.6% | ||
| Q1 24 | 13.3% | -5.3% |
| Q4 25 | 10.8% | — | ||
| Q3 25 | 13.3% | 16.2% | ||
| Q2 25 | 10.1% | 11.2% | ||
| Q1 25 | 9.7% | 6.5% | ||
| Q4 24 | 10.2% | — | ||
| Q3 24 | 10.4% | 25.2% | ||
| Q2 24 | 10.4% | -9.6% | ||
| Q1 24 | 10.4% | -11.0% |
| Q4 25 | $0.42 | $0.26 | ||
| Q3 25 | $0.51 | $0.17 | ||
| Q2 25 | $0.38 | $0.12 | ||
| Q1 25 | $0.34 | $0.06 | ||
| Q4 24 | $0.39 | $0.40 | ||
| Q3 24 | $0.40 | $0.41 | ||
| Q2 24 | $0.41 | $-0.09 | ||
| Q1 24 | $0.39 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.3M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $304.8M | $130.3M |
| Total Assets | $354.3M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.3M | $97.5M | ||
| Q3 25 | $31.9M | $94.4M | ||
| Q2 25 | $32.6M | $96.0M | ||
| Q1 25 | $72.5M | $93.2M | ||
| Q4 24 | $68.6M | $101.0M | ||
| Q3 24 | $122.6M | $96.7M | ||
| Q2 24 | $123.7M | $96.8M | ||
| Q1 24 | $110.9M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $304.8M | $130.3M | ||
| Q3 25 | $305.4M | $115.3M | ||
| Q2 25 | $301.2M | $104.7M | ||
| Q1 25 | $302.0M | $97.1M | ||
| Q4 24 | $297.7M | $92.1M | ||
| Q3 24 | $358.4M | $71.1M | ||
| Q2 24 | $354.4M | $48.5M | ||
| Q1 24 | $349.8M | $51.0M |
| Q4 25 | $354.3M | $216.3M | ||
| Q3 25 | $361.8M | $202.9M | ||
| Q2 25 | $361.7M | $194.9M | ||
| Q1 25 | $348.9M | $196.2M | ||
| Q4 24 | $346.1M | $213.3M | ||
| Q3 24 | $406.8M | $220.7M | ||
| Q2 24 | $406.2M | $205.0M | ||
| Q1 24 | $399.2M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.4M | $14.4M |
| Free Cash FlowOCF − Capex | $15.7M | $14.4M |
| FCF MarginFCF / Revenue | 15.7% | 19.1% |
| Capex IntensityCapex / Revenue | 0.7% | 0.0% |
| Cash ConversionOCF / Net Profit | 1.52× | — |
| TTM Free Cash FlowTrailing 4 quarters | $42.5M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.4M | $14.4M | ||
| Q3 25 | $10.5M | $9.7M | ||
| Q2 25 | $8.0M | $14.1M | ||
| Q1 25 | $12.8M | $3.6M | ||
| Q4 24 | $18.2M | $15.6M | ||
| Q3 24 | $11.8M | $11.0M | ||
| Q2 24 | $23.1M | $1.0M | ||
| Q1 24 | $16.6M | $11.2M |
| Q4 25 | $15.7M | $14.4M | ||
| Q3 25 | $9.0M | $9.7M | ||
| Q2 25 | $6.6M | $14.1M | ||
| Q1 25 | $11.1M | $3.6M | ||
| Q4 24 | $17.5M | $15.6M | ||
| Q3 24 | $10.7M | $11.0M | ||
| Q2 24 | $20.6M | $1.0M | ||
| Q1 24 | $15.0M | — |
| Q4 25 | 15.7% | 19.1% | ||
| Q3 25 | 9.2% | 17.7% | ||
| Q2 25 | 6.8% | 26.8% | ||
| Q1 25 | 12.0% | 7.7% | ||
| Q4 24 | 17.6% | 26.4% | ||
| Q3 24 | 10.8% | 13.7% | ||
| Q2 24 | 20.0% | 2.1% | ||
| Q1 24 | 15.3% | — |
| Q4 25 | 0.7% | 0.0% | ||
| Q3 25 | 1.4% | 0.0% | ||
| Q2 25 | 1.4% | 0.0% | ||
| Q1 25 | 1.8% | 0.1% | ||
| Q4 24 | 0.6% | 0.0% | ||
| Q3 24 | 1.1% | 0.0% | ||
| Q2 24 | 2.4% | 0.0% | ||
| Q1 24 | 1.7% | 0.0% |
| Q4 25 | 1.52× | — | ||
| Q3 25 | 0.80× | 1.10× | ||
| Q2 25 | 0.81× | 2.41× | ||
| Q1 25 | 1.41× | 1.21× | ||
| Q4 24 | 1.78× | — | ||
| Q3 24 | 1.15× | 0.54× | ||
| Q2 24 | 2.16× | — | ||
| Q1 24 | 1.63× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
